Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abbot F Clark

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
BMC Neuroscience|December 21, 2007
Inducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma modelRichard T Libby, Gareth R Howell, Iok-Hou Pang, et al.
The Journal of Clinical Investigation|August 9, 2011
Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucomaGulab S Zode, Markus H Kuehn, Darryl Y Nishimura, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
CRISPR-Cas9-based treatment of myocilin-associated glaucomaAnkur Jain, Gulab Zode, Ramesh B Kasetti, et al.
The Journal of Clinical Investigation|August 4, 2015
Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucomaGulab S Zode, Markus H Kuehn, Darryl Y Nishimura, et al.
American Journal of Ophthalmology|September 16, 2008
Anterior juxtascleral delivery of anecortave acetate in eyes with primary open-angle glaucoma: a pilot investigationAlan L Robin, Abbot F Clark, David W Covert, et al.
Visual Neuroscience|December 8, 2005
Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegenerationRichard T Libby, Michael G Anderson, Iok-Hou Pang, et al.
The Journal of Clinical Investigation|February 16, 2008
Increased expression of the WNT antagonist sFRP-1 in glaucoma elevates intraocular pressureWan-Heng Wang, Loretta G McNatt, Iok-Hou Pang, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Phenethylaminylation: Preliminary <i>In Vitro</i> Evidence for the Covalent Transamidation of Psychedelic Phenethylamines to Glial Proteins using 3,5-Dimethoxy-4-(2-Propynyloxy)-Phenethylamine as a Model CompoundRajiv S Rangan, R Max Petty, Suchismita Acharya, et al.
Research Square|January 10, 2024
Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucomaShruti V Patil, Balasankara Reddy Kaipa, Sujata Ranshing, et al.
Scientific Reports|March 24, 2024
Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucomaShruti V Patil, Balasankara Reddy Kaipa, Sujata Ranshing, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
BMC Neuroscience|December 21, 2007
Inducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma modelRichard T Libby, Gareth R Howell, Iok-Hou Pang, et al.
The Journal of Clinical Investigation|August 9, 2011
Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucomaGulab S Zode, Markus H Kuehn, Darryl Y Nishimura, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
CRISPR-Cas9-based treatment of myocilin-associated glaucomaAnkur Jain, Gulab Zode, Ramesh B Kasetti, et al.
The Journal of Clinical Investigation|August 4, 2015
Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucomaGulab S Zode, Markus H Kuehn, Darryl Y Nishimura, et al.
American Journal of Ophthalmology|September 16, 2008
Anterior juxtascleral delivery of anecortave acetate in eyes with primary open-angle glaucoma: a pilot investigationAlan L Robin, Abbot F Clark, David W Covert, et al.
Visual Neuroscience|December 8, 2005
Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegenerationRichard T Libby, Michael G Anderson, Iok-Hou Pang, et al.
The Journal of Clinical Investigation|February 16, 2008
Increased expression of the WNT antagonist sFRP-1 in glaucoma elevates intraocular pressureWan-Heng Wang, Loretta G McNatt, Iok-Hou Pang, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Phenethylaminylation: Preliminary <i>In Vitro</i> Evidence for the Covalent Transamidation of Psychedelic Phenethylamines to Glial Proteins using 3,5-Dimethoxy-4-(2-Propynyloxy)-Phenethylamine as a Model CompoundRajiv S Rangan, R Max Petty, Suchismita Acharya, et al.
Research Square|January 10, 2024
Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucomaShruti V Patil, Balasankara Reddy Kaipa, Sujata Ranshing, et al.
Scientific Reports|March 24, 2024
Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucomaShruti V Patil, Balasankara Reddy Kaipa, Sujata Ranshing, et al.
Pageof 18